Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130216 · ClinicalTrials.gov registry record
Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 5
- Enrollment target
NCT05130216: Completed study, sponsored by University of Utah.
NCT05130216 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130216 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Determine if genicular nerve radiofrequency ablation (RFA) is a clinically effective intervention for patients with chronic knee pain post-total knee arthroplasty (TKA) as defined by pain.
Primary Outcome
NRS pain score (0 no pain - 10 severe pain)
Interventions
- OTHER Genicular Nerve Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2025-10-01 |
What the finished NCT05130216 record still lists
NCT05130216 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Genicular Nerve Radiofrequency Ablation is the first listed.
NCT05130216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05130216 about?
NCT05130216 is a clinical study titled "Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty". Determine if genicular nerve radiofrequency ablation (RFA) is a clinically effective intervention for patients with chronic knee pain post-total knee arthroplasty (TKA) as defined by pain.
What is the current status of trial NCT05130216?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2021-09-22. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT05130216?
The interventions under investigation include: Genicular Nerve Radiofrequency Ablation (OTHER).
Who is sponsoring clinical trial NCT05130216?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI